24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Although current guidelines advocate early integration of palliative care, symptom burden and palliative care needs of patients at diagnosis of incurable cancer and along the disease trajectory are understudied.

          Material and Methods

          We assessed distress, symptom burden, quality of life, and supportive care needs in patients with newly diagnosed incurable cancer in a prospective longitudinal observational multicenter study. Patients were evaluated using validated self‐report measures (National Comprehensive Cancer Network Distress Thermometer [DT], Functional Assessment of Cancer Therapy [FACT], Schedule for the Evaluation of Individual Quality of Life [SEIQoL‐Q], Patients Health Questionnaire‐4 [PHQ‐4], modified Supportive Care Needs Survey [SCNS‐SF‐34]) at baseline (T0) and at 3 (T1), 6 (T2), and 12 months (T3) follow‐up.

          Results

          From October 2014 to October 2016, 500 patients (219 women, 281 men; mean age 64.2 years) were recruited at 20 study sites in Germany following diagnosis of incurable metastatic, locally advanced, or recurrent lung (217), gastrointestinal (156), head and neck (55), gynecological (57), and skin (15) cancer. Patients reported significant distress (DT score ≥ 5) after diagnosis, which significantly decreased over time (T0: 67.2%, T1: 51.7%, T2: 47.9%, T3: 48.7%). The spectrum of reported symptoms was broad, with considerable variety between and within the cancer groups. Anxiety and depressiveness were most prevalent early in the disease course (T0: 30.8%, T1: 20.1%, T2: 14.7%, T3: 16.9%). The number of patients reporting unmet supportive care needs decreased over time (T0: 71.8 %, T1: 61.6%, T2: 58.1%, T3: 55.3%).

          Conclusion

          Our study confirms a variable and mostly high symptom burden at the time of diagnosis of incurable cancer, suggesting early screening by using standardized tools and underlining the usefulness of early palliative care.

          Implications for Practice

          A better understanding of symptom burden and palliative care needs of patients with newly diagnosed incurable cancer may guide clinical practice and help to improve the quality of palliative care services. The results of this study provide important information for establishing palliative care programs and related guidelines. Distress, symptom burden, and the need for support vary and are often high at the time of diagnosis. These findings underscore the need for implementation of symptom screening as well as early palliative care services, starting at the time of diagnosis of incurable cancer and tailored according to patients’ needs.

          Abstract

          Guidelines recommend early integration of palliative care in the treatment of patients with advanced cancer. This study assessed distress, symptom burden, quality of life, and supportive care needs in patients with newly diagnosed incurable cancer to facilitate future implementation of more effective palliative care services.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          An ultra-brief screening scale for anxiety and depression: the PHQ-4.

          The most common mental disorders in both outpatient settings and the general population are depression and anxiety, which frequently coexist. Both of these disorders are associated with considerable disability. When the disorders co-occur, the disability is even greater. Authors sought to test an ultra-brief screening tool for both. Validated two-item ultra-brief screeners for depression and anxiety were combined to constitute the Patient Health Questionnaire for Depression and Anxiety (the PHQ-4). Data were analyzed from 2,149 patients drawn from 15 primary-care clinics in the United States. Factor analysis confirmed two discrete factors (Depression and Anxiety) that explained 84% of the total variance. Increasing PHQ-4 scores were strongly associated with functional impairment, disability days, and healthcare use. Anxiety had a substantial effect on functional status that was independent of depression. The PHQ-4 is a valid ultra-brief tool for detecting both anxiety and depressive disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Early palliative care for patients with metastatic non-small-cell lung cancer.

            Patients with metastatic non-small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. We examined the effect of introducing palliative care early after diagnosis on patient-reported outcomes and end-of-life care among ambulatory patients with newly diagnosed disease. We randomly assigned patients with newly diagnosed metastatic non-small-cell lung cancer to receive either early palliative care integrated with standard oncologic care or standard oncologic care alone. Quality of life and mood were assessed at baseline and at 12 weeks with the use of the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale and the Hospital Anxiety and Depression Scale, respectively. The primary outcome was the change in the quality of life at 12 weeks. Data on end-of-life care were collected from electronic medical records. Of the 151 patients who underwent randomization, 27 died by 12 weeks and 107 (86% of the remaining patients) completed assessments. Patients assigned to early palliative care had a better quality of life than did patients assigned to standard care (mean score on the FACT-L scale [in which scores range from 0 to 136, with higher scores indicating better quality of life], 98.0 vs. 91.5; P=0.03). In addition, fewer patients in the palliative care group than in the standard care group had depressive symptoms (16% vs. 38%, P=0.01). Despite the fact that fewer patients in the early palliative care group than in the standard care group received aggressive end-of-life care (33% vs. 54%, P=0.05), median survival was longer among patients receiving early palliative care (11.6 months vs. 8.9 months, P=0.02). Among patients with metastatic non-small-cell lung cancer, early palliative care led to significant improvements in both quality of life and mood. As compared with patients receiving standard care, patients receiving early palliative care had less aggressive care at the end of life but longer survival. (Funded by an American Society of Clinical Oncology Career Development Award and philanthropic gifts; ClinicalTrials.gov number, NCT01038271.)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.

              The 4-item Patient Health Questionnaire-4 (PHQ-4) is an ultra-brief self-report questionnaire that consists of a 2-item depression scale (PHQ-2) and a 2-item anxiety scale (GAD-2). Given that PHQ-4, PHQ-2, and GAD-2 have not been validated in the general population, this study aimed to investigate their reliability and validity in a large general population sample and to generate normative data. A nationally representative face-to-face household survey was conducted in Germany in 2006. The survey questionnaire consisted of the PHQ-4, other self-report instruments, and demographic characteristics. Of the 5030 participants (response rate=72.9%), 53.6% were female and mean (SD) age was 48.4 (18.0) years. The sociodemographic characteristics of the study sample closely match those of the total populations in Germany as well as those in the United States. Confirmatory factor analyses showed very good fit indices for a two-factor solution (RMSEA .027; 90% CI .023-.032). All models tested were structurally invariant between different age and gender groups. Construct validity of the PHQ-4, PHQ-2, and GAD-2 was supported by intercorrelations with other self-report scales and with demographic risk factors for depression and anxiety. PHQ-2 and GAD-2 scores of 3 corresponded to percentile ranks of 93.4% and 95.2%, respectively, whereas PHQ-2 and GAD-2 scores of 5 corresponded to percentile ranks of 99.0% and 99.2%, respectively. A criterion standard diagnostic interview for depression and anxiety was not included. Results from this study support the reliability and validity of the PHQ-4, PHQ-2, and GAD-2 as ultra-brief measures of depression and anxiety in the general population. The normative data provided in this study can be used to compare a subject's scale score with those determined from a general population reference group. Copyright 2009 Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Florian.Lordick@medizin.uni-leipzig.de
                Journal
                Oncologist
                Oncologist
                10.1002/(ISSN)1549-490X
                ONCO
                theoncologist
                The Oncologist
                John Wiley & Sons, Inc. (Hoboken, USA )
                1083-7159
                1549-490X
                30 March 2021
                June 2021
                : 26
                : 6 ( doiID: 10.1002/onco.v26.6 )
                : e1058-e1065
                Affiliations
                [ 1 ] Leipzig University Medical Center, University Cancer Center Leipzig Leipzig Germany
                [ 2 ] ENT Department, Leipzig University Medical Center Leipzig Germany
                [ 3 ] Department of Medical Psychology and Medical Sociology, Leipzig University Medical Center Leipzig Germany
                [ 4 ] Department of Radiation Oncology, Kliniken Maria Hilf Mönchengladbach Germany
                [ 5 ] Department of Thoracic Oncology, Translational Lung Research Center Heidelberg TLRC‐H, Thoraxklinik at Heidelberg University Hospital, Member of the German Center for Lung Research DZL Heidelberg Germany
                [ 6 ] Department of Palliative Medicine, University Hospital Heidelberg Heidelberg Germany
                [ 7 ] Department of Hematology, Oncology and Palliative Care, Klinikum Magdeburg Magdeburg Germany
                [ 8 ] Department of Palliative Medicine, University Medical Center Göttingen Göttingen Germany
                [ 9 ] Department of Medical Oncology, Kliniken Essen Mitte Essen Germany
                [ 10 ] Department of Oncology and Hematology, Klinikum Braunschweig Braunschweig Germany
                [ 11 ] Department of Gynecology, Klinikum Südstadt Rostock Rostock Germany
                [ 12 ] 3rd Department of Medicine, Klinikum Leverkusen Leverkusen Germany
                [ 13 ] Skin Cancer Center Rhein‐Main, University Medical Center Mainz Mainz Germany
                [ 14 ] Hematology Oncology and Palliative Care Clinic, Immanuel Klinik und Poliklinik Rüdersdorf Rüdersdorf, Berlin Germany
                [ 15 ] Department of Hematology, Oncology and Palliative Care, Städtisches Klinikum Karlsruhe Karlsruhe Germany
                [ 16 ] Department of Hematology, Oncology and Palliative Care Klinikum Traunstein, Traunstein Germany
                [ 17 ] Department of Oncology and Hematology, University Medical Center Hamburg‐Eppendorf Hamburg Germany
                [ 18 ] Interdisciplinary Department of Palliative Medicine, University Hospital Würzburg Würzburg Germany
                [ 19 ] Department for Gynecology and Obstetrics, University of Regensburg, Caritas Hospital St. Josef Regensburg Germany
                [ 20 ] Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig Leipzig Germany
                Author notes
                [*] [* ]Correspondence: Florian Lordick, M.D., University Cancer Center Leipzig, Leipzig University Medical Center, Liebigstraße 22, 04103 Leipzig, Germany. Telephone: +49 341 97 12560, Fax: +49 341 97 17709; e‐mail: Florian.Lordick@ 123456medizin.uni-leipzig.de
                [†]

                Contributed equally.

                Author information
                https://orcid.org/0000-0001-8759-4144
                Article
                ONCO13751
                10.1002/onco.13751
                8176980
                33687742
                95095616-4d43-4ba8-9532-1cd28f1dd562
                © 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 23 September 2020
                : 24 February 2021
                Page count
                Figures: 2, Tables: 2, Pages: 8, Words: 6924
                Categories
                26
                Symptom Management and Supportive Care
                Symptom Management and Supportive Care
                Custom metadata
                2.0
                June 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.2 mode:remove_FC converted:04.06.2021

                Oncology & Radiotherapy
                palliative care,symptom burden,quality of life,distress,cancer
                Oncology & Radiotherapy
                palliative care, symptom burden, quality of life, distress, cancer

                Comments

                Comment on this article